Stay updated on IPI-145 Plus FCR in CLL Clinical Trial
Sign up to get notified when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.

Latest updates to the IPI-145 Plus FCR in CLL Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedUpdate to v3.2.0 with a government-operating status notice; removal of a specific genetic disease resource (B-cell CLL).SummaryDifference4%
- Check20 days agoChange DetectedUpgrade version from v3.0.2 to v3.1.0; no other content changes are specified.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; Back to Top link removed. No substantive changes to core content.SummaryDifference0.2%
- Check42 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check49 days agoChange DetectedThe web page has been updated to include new facility and location information, as well as additional medical terms related to B-cell chronic lymphocytic leukemia and associated treatments. Several outdated dates and terms have been removed.SummaryDifference7%
- Check63 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12, indicating a revision in the content.SummaryDifference0.5%
Stay in the know with updates to IPI-145 Plus FCR in CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.